Shareholders of Farmak pharmaceutical company re-elect supervisory board, its head
The meeting of shareholders of the largest pharmaceutical company in terms of sales in monetary terms JSC Farmak (Kyiv) has re-elected the supervisory board and its head Filya Zhebrovska.
As the company reported in the information disclosure system of the National Securities and Stock Market Commission, by its decision, the meeting held on June 7 re-elected Hryhoriy Kostiuk, Mykhailo Vanat, Oleh Syarkevich and Victoria Smarodina as members of the supervisory board.
In addition, the meeting terminated the powers of member of the supervisory board Petro Chernyshov and elected Maurice Chagnaud, who previously held senior positions in Advanz Pharma (Canada), MAC Healthcare (Switzerland) and Remedica (Cyprus), as a member of their boards.
Advertising
Advertising
MORE ABOUT
Ukrainian business performs more functions than usual during the war - press conference
16:58, 19.11.2024
Farmak buys marketing pharmaceutical companies in the Czech Republic, Slovakia, Ukraine
10:46, 05.06.2023
Less than 5% of Farmak employees who left Ukraine because of war remain abroad
20:20, 28.04.2023
EBRD provides EUR 20 mln loan to Farmak
18:14, 26.05.2022
Farmak invests over $1.2 mln in MedTech, HealthCare projects and startups
14:13, 05.01.2022
LATEST
Nova Poshta to boost European investment by 42.8% in 2025 – CEO of Nova Post Europe
19:01, 04.04.2025
Vodafone Ukraine sees 30.1% drop in net profit in 2024 despite 13.1% revenue growth
18:03, 04.04.2025
Agricultural exports account for over 50% of all Ukrainian exports - Shmyhal
14:38, 04.04.2025
Epicentr Ceramic Corporation plans to increase share of product exports to 30% in 2025
10:31, 04.04.2025
Epicentr Ceramic Corporation increases production by 25.3% in 2024